Jon LaPook, M.D. is the award-winning chief medical correspondent for CBS News. Since joining CBS News in 2006, LaPook has delivered more than 1,500 reports on a wide variety of breaking news and ...

Scientists are hoping to use genetic engineering to reduce the transmission of Lyme disease. The scientists' target is not ...

Lyme borreliosis is the most common tick-borne infectious disease in Europe. Up to 70,000 new cases are estimated each year in Austria alone. The bacterial infection can cause lasting health problems ...

The following companies are leading this vector-borne boon, each tackling the problem from a different technological angle: ...

The bacteria that cause Lyme disease can persist in the body for months or even years after antibiotic treatment, according to a study in the journal Advances in Infectious Diseases. Researchers ...

Across most of the Northeast, getting bitten by a blacklegged tick-- also called a deer tick -- is a risk during spring, summer, and fall. A new Dartmouth study, published in Parasites and Vectors, ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.